Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: February 2008
-
By Christopher P. Singer — In a notice published on February 13, 2008, the U.S. Patent and Trademark Office announced that it is enhancing the priority document exchange program (PDX) with the European Patent Office (EPO) and Japan Patent Office (JPO). Specifically, in an effort to streamline and simplify the requirements of the…
-
By Christopher P. Singer — An e-Commerce e-Alert sent out today by the U.S. Patent and Trademark Office contained information regarding the upcoming release of new EFS-Web 1.3 enhancements; the availability of all M.P.E.P . Editions; EFS-Web indexing hints for provisional application cover sheets; and tips for submitting images in EFS-Web. New EFS-Web…
-
By Kevin E. Noonan — Earlier today, Patent Docs participated in a conference call with Jim Greenwood (at right), the President and CEO of the Biotechnology Industry Organization (BIO). Mr. Greenwood, who represented Pennsylvania’s Eighth District in the U.S. House of Representatives from January 1993 through January 2005 prior to his BIO appointment,…
-
By Kevin E. Noonan — The Biotechnology Industry Organization (BIO) earlier this week released a report on the purported bases of current patent "reform" efforts that have culminated in passage of a bill in the House of Representatives (H.R. 1908) and consideration of another bill by the Senate (S. 1145). The Senate bill…
-
By Donald Zuhn — Insmed Inc., a biopharmaceutical company based in Richmond, VA, announced last week that it was launching a campaign on the importance of establishing a regulatory pathway in the U.S. for follow-on biologics (sometimes referred to as biosimilars or biogenerics). Last summer, we reported that the U.S. Senate Committee on…
-
By Donald Zuhn — Last week, Jon Dudas (at right), Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO), presented the President’s fiscal year 2009 budget request for the USPTO. The Bush Administration is seeking $2.075 billion for the Patent Office, which represents an 8%…
-
By Kevin E. Noonan — John White (at right) of the PLI Patent Blog came to visit some of the Patent Docs today, and he had more to say about the summary judgment hearing in Tafas/GSK v. Dudas held last Friday in the Eastern District of Virginia before Judge James C. Cacheris. Readers…
-
By Christopher P. Singer — On February 7, 2008, Human Genome Sciences, Inc. (HGS) and Xencor, Inc. announced that the two companies will enter a collaboration agreement relating to Xencor’s proprietary XmAb™ humanization and optimization technologies. Xencor’s technology will be applied to several new monoclonal antibody drug candidates developed against antigens discovered by…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. SB Pharmco Puerto Rico, Inc. d/b/a GlaxoSmithKline et al. v. Mutual Pharmaceutical Company, Inc. et al.2:08-cv-00549; filed February 4, 2008 in the…
-
February 15, 2008 – Patent Claim Construction (Law Seminars International) – Chicago, IL February 25-26, 2008 – Pharma/Biotech Patent Claim Drafting and Prosecution (American Conference Institute) – New York, NY*** February 25-26, 2008 – Strategic Intellectual Property Planning (American Conference Institute) – Scottsdale, AZ March 12, 2008 – Biotechnology, Chemical & Pharmaceutical Art Group Customer…
Patent Docs 